Andrew Antoszyk
Ophthalmology · Charlotte, NCNPI 1427016443
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (35.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Cardinal Health 108 LLC at 31.2% of the total. Reporting peaked in 2019 at $2,498 and has fallen 73.6% since, to $659 in 2022.
Across 40 payments — averaging $126.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardinal Health 108 LLC$2K
- Genentech, Inc.$2K
- Novartis$826
- Notal Vision, Inc.$568
- Genentech USA, Inc.$192
- Regeneron Healthcare Solutions, Inc.$122
- plus $229 from 7 others
Across 231 payments — averaging $17,492 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$2.9M
- Novartis$986K
- Apellis Pharmaceuticals, Inc.$137K
- Boehringer Ingelheim$36K
- F. Hoffmann-la Roche AG$10K
- Roche TCRC, Inc.$7K
- plus $2K from 1 others
What the payments were for
- Consulting fees$1,57531%
- Speaking & faculty fees$56811%
- Travel & lodging$1,13322%
- Food & beverage$1,78035%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardinal Health 108 LLC | 1 | $1,575 |
| Genentech, Inc. | 10 | $1,543 |
| Novartis | 8 | $826 |
| Notal Vision, Inc. | 1 | $568 |
| Genentech USA, Inc. | 9 | $192 |
| Regeneron Healthcare Solutions, Inc. | 3 | $122 |
| Boehringer Ingelheim | 1 | $92 |
| Apellis Pharmaceuticals, Inc. | 2 | $34 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $33 |
| Carl Zeiss Meditec USA, Inc. | 1 | $21 |
| AbbVie | 1 | $20 |
| Alimera Sciences, Inc. | 1 | $16 |
| Spark Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Non-Covered Product$896
- BEOVU$657
- Lucentis$246
How this compares
$5,056 in reported general payments places this provider in the 80th percentile of 588 ophthalmology providers in North Carolina.
Other ophthalmology in Charlotte
- Thomas MundorfCharlotte$220K
- Charles BlotnickCharlotte$18K
- Adrian ElfersyCharlotte$13K
- Joseph KrugCharlotte$10K
- Royce SyracuseCharlotte$10K
- William HammondsCharlotte$9K
- Preeya GuptaRaleigh$1.8M
- Julie WoodwardDurham$1M
- Rajiv ShahWinston Salem$909K
- Lejla VajzovicDurham$681K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.